Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001362310-09-002007
Filing Date
2009-02-13
Accepted
2009-02-13 16:12:50
Documents
1
Group Members
UBS AG

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/AMENDMENT NO. 1 c80763sc13gza.htm SC 13G/A 25587
  Complete submission text file 0001362310-09-002007.txt   27519
Mailing Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601
Business Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601 2019680980
DOV PHARMACEUTICAL INC (Subject) CIK: 0001066833 (see all company filings)

EIN.: 223374365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-78237 | Film No.: 09603625
SIC: 2834 Pharmaceutical Preparations

Mailing Address BAHNHOFSTRASSE 45 P O BOX CH 8098 ZURICH V8 -
Business Address BAHNHOFSTRASSE 45 P O BOX CH 8098 ZURICH V8 - 41-1-234-4100
UBS AG (Filed by) CIK: 0001114446 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks